".....But simply being able to
predict who will do better and who will do worse is of little value to
the patient, other than knowing who needs to get their affairs in order
more quickly. Clinical utility depends on actually being able to shape
treatment choices based on the information provided in an assay.
Can CTCs do that? Maybe....."
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.